Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBF-677 in mild to moderate ulcerative colitis
NCT03773952Phase 2Completed
- Sponsor
- Palobiofarma
- Start
- Jul 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PBF-677 in ulcerative colitis (UC), sponsored by Palobiofarma. Started Jul 2018; status: completed.
02
Drugs
PBF-677
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03773952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03773952.